Sanofi India, a company in the Pharmaceuticals industry, reported revenue of ₹492 crore and net profit of ₹117 crore for the September 2026 quarter.
Sanofi India (NSE: SANOFI) closed at ₹3,206.10 on 20 Nov 2026, down 29.8% over the past year. Its market capitalisation is ₹7,384 crore and it trades at 20.3 times earnings.
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.